|
1
|
Binker MG, Binker-Cosen MJ, Binker-Cosen
AA and Cosen-Binker LI: Microenvironmental factors and
extracellular matrix degradation in pancreatic cancer. JOP.
15:280–285. 2014.PubMed/NCBI
|
|
2
|
Erkan M: Understanding the stroma of
pancreatic cancer: Co-evolution of the microenvironment with
epithelial carcinogenesis. J Pathol. 231:4–7. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lunardi S, Muschel RJ and Brunner TB: The
stromal compartments in pancreatic cancer: Are there any
therapeutic targets? Cancer Lett. 343:147–155. 2014. View Article : Google Scholar
|
|
4
|
Grzesiak JJ, Ho JC, Moossa AR and Bouvet
M: The integrin-extracellular matrix axis in pancreatic cancer.
Pancreas. 35:293–301. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grzesiak JJ, Tran Cao HS, Burton DW,
Kaushal S, Vargas F, Clopton P, Snyder CS, Deftos LJ, Hoffman RM
and Bouvet M: Knockdown of the beta(1) integrin subunit reduces
primary tumor growth and inhibits pancreatic cancer metastasis. Int
J Cancer. 129:2905–2915. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Walsh N, Clynes M, Crown J and O'Donovan
N: Alterations in integrin expression modulates invasion of
pancreatic cancer cells. J Exp Clin Cancer Res. 28:1402009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yao H, Zeng ZZ, Fay KS, Veine DM,
Staszewski ED, Morgan M, Wilder-Romans K, Williams TM, Spalding AC,
Ben-Josef E, et al: Role of α5β1 integrin up-regulation in
radiation-induced invasion by human pancreatic cancer cells. Transl
Oncol. 4:282–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hilbig A: Src kinase and pancreatic
cancer. Recent Results Cancer Res. 177:179–185. 2008. View Article : Google Scholar
|
|
9
|
Je DW, O YM, Ji YG, Cho Y and Lee DH: The
inhibition of SRC family kinase suppresses pancreatic cancer cell
proliferation, migration, and invasion. Pancreas. 43:768–776. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma YC, Shi C, Zhang YN, Wang LG, Liu H,
Jia HT, Zhang YX, Sarkar FH and Wang ZS: The tyrosine kinase c-Src
directly mediates growth factor-induced Notch-1 and Furin
interaction and Notch-1 activation in pancreatic cancer cells. PLoS
One. 7:e334142012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nagathihalli NS and Merchant NB:
Src-mediated regulation of E-cadherin and EMT in pancreatic cancer.
Front Biosci (Landmark Ed). 17:2059–2069. 2012. View Article : Google Scholar
|
|
12
|
Chaimowitz NS, Falanga YT, Ryan JJ and
Conrad DH: Fyn kinase is required for optimal humoral responses.
PLoS One. 8:e606402013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chapman NM, Yoder AN and Houtman JC:
Non-catalytic functions of Pyk2 and Fyn regulate late stage
adhesion in human T cells. PLoS One. 7:e530112012. View Article : Google Scholar
|
|
14
|
Du CP, Tan R and Hou XY: Fyn kinases play
a critical role in neuronal apoptosis induced by oxygen and glucose
deprivation or amyloid-β peptide treatment. CNS Neurosci Ther.
18:754–761. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yadav V and Denning MF: Fyn is induced by
Ras/PI3K/Akt signaling and is required for enhanced
invasion/migration. Mol Carcinog. 50:346–352. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen ZY, Cai L, Bie P, Wang SG, Jiang Y,
Dong JH and Li XW: Roles of Fyn in pancreatic cancer metastasis. J
Gastroenterol Hepatol. 25:293–301. 2010. View Article : Google Scholar
|
|
17
|
Kapp TG, Rechenmacher F, Sobahi TR and
Kessler H: Integrin modulators: a patent review. Expert Opin Ther
Pat. 23:1273–1295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Landowski TH, Gard J, Pond E, Pond GD,
Nagle RB, Geffre CP and Cress AE: Targeting integrin α6 stimulates
curative-type bone metastasis lesions in a xenograft model. Mol
Cancer Ther. 13:1558–1566. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun C, Zargham R, Shao Q, Gui X, Marcus V,
Lazaris A, Salman A, Metrakos P, Qu X and Gao Z: Association of
CD98, integrin β1, integrin β3 and Fak with the progression and
liver metastases of colorectal cancer. Pathol Res Pract.
210:668–674. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moro L, Perlino E, Marra E, Languino LR
and Greco M: Regulation of beta1C and beta1A integrin expression in
prostate carcinoma cells. J Biol Chem. 279:1692–1702. 2004.
View Article : Google Scholar
|
|
21
|
Gauck S, Schultheiss HP, Rauch U and
Eisenreich A: Modulation of the isoform expression of Cyr61 and
Integrin-αv in human microvascular endothelial cells. Cardiovasc
Syst. 1:82013. View Article : Google Scholar
|
|
22
|
de Melker AA and Sonnenberg A: Integrins:
Alternative splicing as a mechanism to regulate ligand binding and
integrin signaling events. BioEssays. 21:499–509. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fornaro M, Steger CA, Bennett AM, Wu JJ
and Languino LR: Differential role of β1C and
β1A integrin cytoplasmic variants in modulating focal
adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated
protein kinase pathways. Mol Biol Cell. 11:2235–2249. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moro L, Greco M, Maiorano E, Selvaggi L,
Marra E and Perlino E: Transcriptional regulation of beta1 integrin
expression in the physio/pathological states of human endometrial
tissues. Int J Oncol. 26:457–465. 2005.PubMed/NCBI
|
|
25
|
Eisenreich A: Regulation of vascular
function on posttranscriptional level. Thrombosis. 2013:9487652013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Barash Y and Garcia JV: Predicting
alternative splicing. Methods Mol Biol. 1126:411–423. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kotlajich MV, Crabb TL and Hertel KJ:
Spliceosome assembly pathways for different types of alternative
splicing converge during commitment to splice site pairing in the A
complex. Mol Cell Biol. 29:1072–1082. 2009. View Article : Google Scholar :
|
|
28
|
Schor IE, Gómez Acuña LI and Kornblihtt
AR: Coupling between transcription and alternative splicing. Cancer
Treat Res. 158:1–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Verbeeren J, Niemelä EH, Turunen JJ, Will
CL, Ravantti JJ, Lührmann R and Frilander MJ: An ancient mechanism
for splicing control: U11 snRNP as an activator of alternative
splicing. Mol Cell. 37:821–833. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang T, Huang XH, Dong L, Hu D, Ge C,
Zhan YQ, Xu WX, Yu M, Li W, Wang X, et al: PCBP-1 regulates
alternative splicing of the CD44 gene and inhibits invasion in
human hepatoma cell line HepG2 cells. Mol Cancer. 9:722010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Barboro P, Ferrari N and Balbi C: Emerging
roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in
cancer progression. Cancer Lett. 352:152–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dery KJ, Gaur S, Gencheva M, Yen Y,
Shively JE and Gaur RK: Mechanistic control of carcinoembryonic
antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms
by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP
A1, and hnRNP M. J Biol Chem. 286:16039–16051. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Garayoa M, Man YG, Martínez A, Cuttitta F
and Mulshine JL: Downregulation of hnRNP A2/B1 expression in tumor
cells under prolonged hypoxia. Am J Respir Cell Mol Biol. 28:80–85.
2003. View Article : Google Scholar
|
|
34
|
Chaudhury A, Hussey GS, Ray PS, Jin G, Fox
PL and Howe PH: TGF-beta-mediated phosphorylation of hnRNP E1
induces EMT via transcript-selective translational induction of
Dab2 and ILEI. Nat Cell Biol. 12:286–293. 2010.PubMed/NCBI
|
|
35
|
Zhang HY and Dou KF: PCBP1 is an important
mediator of TGF-β-induced epithelial to mesenchymal transition in
gall bladder cancer cell line GBC-SD. Mol Biol Rep. 41:5519–5524.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen ZY, Cai L, Zhu J, Chen M, Chen J, Li
ZH, Liu XD, Wang SG, Bie P, Jiang P, et al: Fyn requires HnRNPA2B1
and Sam68 to synergistically regulate apoptosis in pancreatic
cancer. Carcinogenesis. 32:1419–1426. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Meng Q, Rayala SK, Gururaj AE, Talukder
AH, O'Malley BW and Kumar R: Signaling-dependent and coordinated
regulation of transcription, splicing, and translation resides in a
single coregulator, PCBP1. Proc Natl Acad Sci USA. 104:5866–5871.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lian WX, Yin RH, Kong XZ, Zhang T, Huang
XH, Zheng WW, Yang Y, Zhan YQ, Xu WX, Yu M, et al: THAP11, a novel
binding protein of PCBP1, negatively regulates CD44 alternative
splicing and cell invasion in a human hepatoma cell line. FEBS
Lett. 586:1431–1438. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hodson MJ, Hudson AJ, Cherny D and Eperon
IC: The transition in spliceosome assembly from complex E to
complex A purges surplus U1 snRNPs from alternative splice sites.
Nucleic Acids Res. 40:6850–6862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ritchie DB, Schellenberg MJ and MacMillan
AM: Spliceosome structure: Piece by piece. Biochim Biophys Acta.
1789:624–633. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shcherbakova I, Hoskins AA, Friedman LJ,
Serebrov V, Corrêa IR Jr, Xu MQ, Gelles J and Moore MJ: Alternative
spliceosome assembly pathways revealed by single-molecule
fluorescence microscopy. Cell Rep. 5:151–165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
van der Feltz C, Anthony K, Brilot A and
Pomeranz Krummel DA: Architecture of the spliceosome. Biochemistry.
51:3321–3333. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Will CL and Lührmann R: Spliceosome
structure and function. Cold Spring Harb Perspect Biol. 3:32011.
View Article : Google Scholar
|
|
44
|
Svineng G, Fässler R and Johansson S:
Identification of beta1C-2 a novel variant of the integrin beta1
subunit generated by utilization of an alternative splice acceptor
site in exon C. Biochem J. 330:1255–1263. 1998. View Article : Google Scholar
|
|
45
|
Busch A and Hertel KJ: Evolution of SR
protein and hnRNP splicing regulatory factors. Wiley Interdiscip
Rev RNA. 3:1–12. 2012. View Article : Google Scholar
|
|
46
|
Manzotti M, Dell'Orto P, Maisonneuve P,
Fornaro M, Languino LR and Viale G: Down-regulation of
β1C integrin in breast carcinomas correlates with high
proliferative fraction, high histological grade, and larger size.
Am J Pathol. 156:169–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Meredith JE Jr, Kiosses WB, Takada Y and
Schwartz MA: Mutational analysis of cell cycle inhibition by
integrin beta1C. J Biol Chem. 274:8111–8116. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Moro L, Greco M, Ditonno P, Battaglia M,
Marra E and Perlino E: Transcriptional regulation of the beta1C
integrin splice variant in human prostate adenocarcinoma. Int J
Oncol. 23:1601–1606. 2003.PubMed/NCBI
|
|
49
|
Perlino E, Lovecchio M, Vacca RA, Fornaro
M, Moro L, Ditonno P, Battaglia M, Selvaggi FP, Mastropasqua MG,
Bufo P, et al: Regulation of mRNA and protein levels of beta1
integrin variants in human prostate carcinoma. Am J Pathol.
157:1727–1734. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Saito YD, Jensen AR, Salgia R and Posadas
EM: Fyn: A novel molecular target in cancer. Cancer. 116:1629–1637.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Paronetto MP, Achsel T, Massiello A,
Chalfant CE and Sette C: The RNA-binding protein Sam68 modulates
the alternative splicing of Bcl-x. J Cell Biol. 176:929–939. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mattioli C, Pianigiani G and Pagani F:
Cross talk between spliceosome and microprocessor defines the fate
of pre-mRNA. Wiley Interdiscip Rev RNA. 5:647–658. 2014.PubMed/NCBI
|
|
53
|
Wahl MC, Will CL and Lührmann R: The
spliceosome: Design principles of a dynamic RNP machine. Cell.
136:701–718. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Han SP, Tang YH and Smith R: Functional
diversity of the hnRNPs: Past, present and perspectives. Biochem J.
430:379–392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Eisenreich A, Boltzen U, Poller W,
Schultheiss HP and Rauch U: Effects of the Cdc2-like kinase-family
and DNA topoisomerase I on the alternative splicing of eNOS in
TNF-alpha-stimulated human endothelial cells. Biol Chem.
389:1333–1338. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Eisenreich A, Bogdanov VY, Zakrzewicz A,
Pries A, Antoniak S, Poller W, Schultheiss HP and Rauch U:
Cdc2-like kinases and DNA topoisomerase I regulate alternative
splicing of tissue factor in human endothelial cells. Circ Res.
104:589–599. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Eisenreich A, Zakrzewicz A, Huber K,
Thierbach H, Pepke W, Goldin-Lang P, Schultheiss HP, Pries A and
Rauch U: Regulation of pro-angiogenic tissue factor expression in
hypoxia-induced human lung cancer cells. Oncol Rep. 30:462–470.
2013.PubMed/NCBI
|
|
58
|
Howard JM and Sanford JR: The RNAissance
family: SR proteins as multifaceted regulators of gene expression.
Wiley Interdiscip Rev RNA. 6:93–110. 2015. View Article : Google Scholar
|
|
59
|
Bonomi S, di Matteo A, Buratti E, Cabianca
DS, Baralle FE, Ghigna C and Biamonti G: HnRNP A1 controls a
splicing regulatory circuit promoting mesenchymal-to-epithelial
transition. Nucleic Acids Res. 41:8665–8679. 2013. View Article : Google Scholar : PubMed/NCBI
|
